Submit a Review & Earn an Amazon Gift Card
You can now submit reviews for your favorite Tocris products. Your review will help other researchers decide on the best products for their research. Why not submit a review today?!
Submit ReviewKHS 101 hydrochloride is a selective inducer of neuronal differentiation; induces neuronal differentiation in cultured hippocampal neural progenitor cells (NPCs) by interacting with TACC3 (EC50 ~1 μM). Suppresses astrocyte formation. Also induces acceleration of neuronal differentiation in the hippocampal dentate gyrus in vivo.
KHS 101 hydrochloride is also offered as part of the Tocriscreen 2.0 Max and Tocriscreen Stem Cell Library. Find out more about compound libraries available from Tocris.
M. Wt | 375.92 |
Formula | C18H21N5S.HCl |
Storage | Desiccate at RT |
Purity | ≥98% (HPLC) |
CAS Number | 1784282-12-7 |
PubChem ID | 90488983 |
InChI Key | INVQHPQJFRKGIO-UHFFFAOYSA-N |
Smiles | CC(C)CNC1=NC(NCC2=CSC(C3=CC=CC=C3)=N2)=NC=C1.Cl |
The technical data provided above is for guidance only. For batch specific data refer to the Certificate of Analysis.
Tocris products are intended for laboratory research use only, unless stated otherwise.
Solvent | Max Conc. mg/mL | Max Conc. mM | |
---|---|---|---|
Solubility | |||
DMSO | 18.8 | 50 | |
ethanol | 18.8 | 50 |
The following data is based on the product molecular weight 375.92. Batch specific molecular weights may vary from batch to batch due to the degree of hydration, which will affect the solvent volumes required to prepare stock solutions.
Concentration / Solvent Volume / Mass | 1 mg | 5 mg | 10 mg |
---|---|---|---|
0.5 mM | 5.32 mL | 26.6 mL | 53.2 mL |
2.5 mM | 1.06 mL | 5.32 mL | 10.64 mL |
5 mM | 0.53 mL | 2.66 mL | 5.32 mL |
25 mM | 0.11 mL | 0.53 mL | 1.06 mL |
References are publications that support the biological activity of the product.
Wurdak et al (2010) A small molecule accelerates neuronal differentiation in the adult rat. Proc.Natl.Acad.Sci.USA. 107 16542 PMID: 20823227
If you know of a relevant reference for KHS 101 hydrochloride, please let us know.
Keywords: KHS 101 hydrochloride, KHS 101 hydrochloride supplier, KHS101, hydrochloride, transforming, acidic, coiled-coil-containing, protein, 3, TACC3, NPC, hippocampal, neural, progenitors, cells, neuronal, differentiation, maturing, neurons, differentiated, selective, activators, [1262770-73-9], Neural, Stem, Cells, 4888, Tocris Bioscience
Citations are publications that use Tocris products. Selected citations for KHS 101 hydrochloride include:
Henrik Daa et al (2021) Metabolic impairment of non-small cell lung cancers by mitochondrial HSPD1 targeting. J Exp Clin Cancer Res 40 248 PMID: 34364401
Do you know of a great paper that uses KHS 101 hydrochloride from Tocris? Please let us know.
There are currently no reviews for this product. Be the first to review KHS 101 hydrochloride and earn rewards!
$50/€35/£30/$50CAN/¥300 Yuan/¥5000 Yen for first to review with an image
$25/€18/£15/$25CAN/¥75 Yuan/¥2500 Yen for a review with an image
$10/€7/£6/$10 CAD/¥70 Yuan/¥1110 Yen for a review without an image
Tocris offers the following scientific literature in this area to showcase our products. We invite you to request* your copy today!
*Please note that Tocris will only send literature to established scientific business / institute addresses.
This product guide provides a background to Huntington's disease research and lists around 100 products for the study of:
Written by Kirsty E. Clarke, Victoria B. Christie, Andy Whiting and Stefan A. Przyborski, this review provides an overview of the use of small molecules in the control of stem cell growth and differentiation. Key signaling pathways are highlighted, and the regulation of ES cell self-renewal and somatic cell reprogramming is discussed. Compounds available from Tocris are listed.
Huntington's disease (HD) is a severe monogenic neurodegenerative disorder, which is characterized by the prevalent loss of GABAergic medium spiny neurons (MSN) in the striatum. This poster summarizes the effects of mutant huntingtin aggregation implicated in the pathology of HD, as well as highlighting the use of iPSCs for HD modeling.
Parkinson's disease (PD) causes chronic disability and is the second most common neurodegenerative condition. This poster outlines the neurobiology of the disease, as well as highlighting current therapeutic treatments for symptomatic PD, and emerging therapeutic strategies to delay PD onset and progression.
Stem cells have potential as a source of cells and tissues for research and treatment of disease. This poster summarizes some key protocols demonstrating the use of small molecules across the stem cell workflow, from reprogramming, through self-renewal, storage and differentiation to verification. Advantages of using small molecules are also highlighted.